48
Participants
Start Date
May 31, 2014
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
Recombinant Human Thrombopoietin (rhTPO)
rhTPO was given intravenously at a dose of300Units/kg ,daily for 14 consecutive days;at a dose of 300Units/kg ,one times every other day for 7 times; or at a dose of 300Units/kg ,daily for 7 consecutive days
Qilu Hospital, Shandong University, Jinan
The First Affiliated Hospital of Dalian Medical University
OTHER
Shandong Provincial Hospital
OTHER_GOV
Shandong University
OTHER